Shopping Cart
- Remove All
- Your shopping cart is currently empty
CJ-13,610 is an orally active and nonredox-type inhibitor of 5-lipoxygenase (5-LOX). CJ-13,610 inhibits the biosynthesis of leukotriene B4 and regulates the expression of IL-6 mRNA in macrophages.
Description | CJ-13,610 is an orally active and nonredox-type inhibitor of 5-lipoxygenase (5-LOX). CJ-13,610 inhibits the biosynthesis of leukotriene B4 and regulates the expression of IL-6 mRNA in macrophages. |
In vitro | CJ-13,610 dose-dependently suppresses 5-LOX product formation in ionophore A23187-stimulated polymorphonuclear in the absence of exogenous arachidonic acid with an IC50 of about 70 nM[1]. |
Alias | CJ-13610, CJ 13610 |
Molecular Weight | 393.5 |
Formula | C22H23N3O2S |
Cas No. | 179420-17-8 |
Smiles | C(N)(=O)C1(CCOCC1)C2=CC(SC3=CC=C(C=C3)N4C(C)=NC=C4)=CC=C2 |
Relative Density. | 1.27 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.